Aleksey Yefremov Analyst PerformanceAnalyst at BarclaysAleksey Yefremov is a stock analyst at Barclays across a range of sectors, covering 29 publicly traded companies. Over the past year, Aleksey Yefremov has issued 26 stock ratings, including buy and hold recommendations. While full access to Aleksey Yefremov's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Aleksey Yefremov's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings114 Last 11 YearsBuy Recommendations83.49% 91 Buy RatingsCompanies Covered29 Unique Companies Ratings Distribution109RatingsDistribution of strong buy, buy, hold, and sell ratings by Aleksey Yefremov.RatingPercentageCount Strong Buy0.0%0 ratings Buy83.5%91 ratings Hold14.7%16 ratings Sell1.8%2 ratingsOut of 109 total stock ratings issued by Aleksey Yefremov at Barclays, the majority (83.5%) have been Buy recommendations, followed by 14.7% Hold and 1.8% Sell.Best & Worst CallsBest Call0000.0%ALBMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ODDJul 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE75.9% of companies on NYSE22 companiesNASDAQ24.1% of companies on NASDAQ7 companiesAleksey Yefremov, an analyst at Barclays, currently covers 29 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageMaterials17 companies58.6%Healthcare4 companies13.8%Communication Services4 companies13.8%Technology2 companies6.9%Industrials1 company3.4%Consumer Staples1 company3.4%Aleksey Yefremov of Barclays specializes in stock coverage within the Materials sector, with additional focus on Healthcare and Communication Services companies.Coverage IndustriesIndustryPercentageCHEMICALS17 companies58.6%HEALTHCARE TECHNOLOGY3 companies10.3%SEMICONDUCTORS & SEMICONDUCTOR EQUIPMENT2 companies6.9%INTERACTIVE MEDIA & SERVICES2 companies6.9%INDUSTRIAL CONGLOMERATES1 company3.4%PERSONAL CARE PRODUCTS1 company3.4%HEALTHCARE PROVIDERS & SERVICES1 company3.4%ENTERTAINMENT1 company3.4%MEDIA1 company3.4% Aleksey Yefremov's Ratings History at Barclays Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsLYBLyondellBasell Industries3/4/2026Upgrade$58.20$73.00Overweight$0.0000.00% ROIDOWDOW3/4/2026Upgrade$30.75$38.00Overweight$0.0000.00% ROIAVNTAvient3/4/2026Reiterated Rating$40.13Sector Weight$0.0000.00% ROIECVTEcovyst2/27/2026Boost Price Target$11.47$14.00Overweight$0.0000.00% ROIQQnity Electronics2/27/2026Boost Price Target$124.71$147.00Overweight$0.0000.00% ROIESIElement Solutions2/19/2026Boost Price Target$33.70$36.00Overweight$0.0000.00% ROIAVNTAvient2/13/2026Boost Price Target$41.81$56.00Overweight$0.0000.00% ROIENTGEntegris2/11/2026Boost Price Target$133.44$156.00Overweight$0.0000.00% ROIDDDuPont de Nemours2/11/2026Boost Price Target$148.02$171.00Overweight$0.0000.00% ROIEMNEastman Chemical2/2/2026Reiterated Rating$69.01Overweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. OLNOlin2/2/2026Lower Price Target$20.82$26.00Overweight$0.0000.00% ROIENTGEntegris1/9/2026Boost Price Target$99.85$111.00Overweight$0.0000.00% ROIEMNEastman Chemical1/9/2026Lower Price Target$68.88$74.00Overweight$0.0000.00% ROIAVNTAvient1/9/2026Boost Price Target$33.03$50.00Overweight$0.0000.00% ROIDDDuPont de Nemours1/9/2026Boost Price Target$131.58$153.00Overweight$0.0000.00% ROIFMCFMC12/22/2025Reiterated Rating$13.24Sector Weight$0.0000.00% ROIECVTEcovyst11/10/2025Lower Price Target$8.41$11.00Overweight$0.0000.00% ROIDDDuPont de Nemours11/5/2025Lower Price Target$113.16$132.00Overweight$0.0000.00% ROIFMCFMC10/31/2025Reiterated Rating$15.48Sector Weight$0.0000.00% ROIESIElement Solutions10/30/2025Boost Price Target$26.38$34.00Overweight$0.0000.00% ROIOLNOlin10/29/2025Lower Price Target$21.06$29.00Overweight$0.0000.00% ROIPHRPhreesia10/8/2025Lower Price Target$23.41$32.00Overweight$00.0000.00% ROICTVACorteva10/3/2025Reiterated Rating$63.27Sector Weight$00.0000.00% ROIDDDuPont de Nemours9/22/2025Boost Price Target$98.01$116.74Overweight$000.0000.00% ROIAVNTAvient9/17/2025Initiated Coverage$35.79$48.00Overweight$00.0000.00% ROIAVNTAvient9/16/2025Initiated Coverage$35.95$48.00Overweight$00.0000.00% ROICECelanese8/13/2025Lower Price Target$41.25$70.00Overweight$00.0000.00% ROICTVACorteva8/8/2025Boost Price Target$71.02$85.00Overweight$00.0000.00% ROIDDDuPont de Nemours8/6/2025Boost Price Target$90.89$115.48Overweight$000.0000.00% ROIEMNEastman Chemical8/4/2025Set Price Target$61.29$79.00Overweight$00.0000.00% ROIESIElement Solutions8/1/2025Boost Price Target$23.60$30.00Overweight$00.0000.00% ROIENTGEntegris7/31/2025Reiterated Rating$78.13$103.00Overweight$000.0000.00% ROIOLNOlin7/30/2025Lower Price Target$20.90$31.00Overweight$00.0000.00% ROICTVACorteva7/14/2025Boost Price Target$73.50$84.00Overweight$00.0000.00% ROIVEEVVeeva Systems7/14/2025Boost Price Target$275.82$325.00Overweight$000.0000.00% ROISDGRSchrodinger7/14/2025Lower Price Target$21.01$30.00Overweight$00.0000.00% ROIPHRPhreesia7/14/2025Boost Price Target$26.74$35.00Overweight$00.0000.00% ROIOLNOlin7/14/2025Lower Price Target$21.90$32.00Overweight$00.0000.00% ROIODDODDITY Tech7/14/2025Boost Price Target$71.17$90.00Overweight$00.0000.00% ROILFMDLifeMD7/14/2025Boost Price Target$11.26$14.00Overweight$0.0000.00% ROIA new income category is drawing serious money - here's why (Ad)Forbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the eye-popping yields are fueling a boom among everyday investors. Three years ago, barely a dozen of these funds existed - today there are more than 100, holding over $140 billion. These funds trade on the NYSE and NASDAQ and are built to generate monthly income. Some investors are targeting $5,000 a month with roughly one-tenth of the nest egg Wall Street says you need.Watch the short briefing to see how this income approach worksFMCFMC7/14/2025Boost Price Target$42.42$61.00Overweight$00.0000.00% ROIENTGEntegris7/14/2025Lower Price Target$87.58$112.00Overweight$000.0000.00% ROICTVACorteva5/9/2025Boost Price Target$66.98$72.00Overweight$00.0000.00% ROIENTGEntegris5/8/2025Lower Price Target$80.03$117.00Overweight$000.0000.00% ROIFMCFMC5/2/2025Boost Price Target$38.09$53.00Overweight$00.0000.00% ROIALBAlbemarle5/2/2025Lower Price Target$59.95$95.00Overweight$000.0000.00% ROIEMNEastman Chemical4/28/2025Lower Price Target$76.08$106.00Overweight$00.0000.00% ROIOLNOlin4/14/2025Lower Price Target$20.93$34.00Overweight$00.0000.00% ROIFMCFMC4/14/2025Lower Price Target$37.48$49.00Overweight$00.0000.00% ROIENTGEntegris4/14/2025Lower Price Target$72.12$130.00Overweight$000.0000.00% ROIEMNEastman Chemical4/14/2025Lower Price Target$79.47$120.00Overweight$00.0000.00% ROIESIElement Solutions4/3/2025Initiated Coverage$22.71$29.00Overweight$00.0000.00% ROIFMCFMC2/18/2025Lower Price Target$37.65$51.00Overweight$00.0000.00% ROIALBAlbemarle2/14/2025Lower Price Target$80.86$122.00Overweight$000.0000.00% ROIENTGEntegris2/7/2025Lower Price Target$108.02$141.00Overweight$000.0000.00% ROICTVACorteva2/7/2025Boost Price Target$64.36$70.00Overweight$00.0000.00% ROIEMNEastman Chemical2/3/2025Boost Price Target$99.52$128.00Overweight$00.0000.00% ROIOLNOlin2/3/2025Lower Price Target$29.24$40.00Overweight$00.0000.00% ROISPOTSpotify Technology1/31/2025Boost Price Target$558.67$600.00Overweight$000.0000.00% ROIMETAMeta Platforms1/29/2025Boost Price Target$671.91$750.00Overweight$000.0000.00% ROITTDTrade Desk1/10/2025Boost Price Target$119.81$140.00Overweight$00.0000.00% ROISPOTSpotify Technology1/10/2025Boost Price Target$478.87$555.00Overweight$000.0000.00% ROIPINSPinterest1/10/2025Lower Price Target$30.91$37.00Overweight$00.0000.00% ROIOLNOlin1/10/2025Lower Price Target$31.29$50.00Overweight$00.0000.00% ROIMETAMeta Platforms1/10/2025Boost Price Target$605.86$700.00Overweight$000.0000.00% ROIENTGEntegris1/10/2025Lower Price Target$98.36$150.00Overweight$000.0000.00% ROICTVACorteva1/10/2025Lower Price Target$56.40$68.00Overweight$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
